ARRAY BIOPHARMA INC 4
4 · ARRAY BIOPHARMA INC · Filed Dec 24, 2008
Insider Transaction Report
Form 4
SNITMAN DAVID
DirectorCOO and VP, Business Devel.
Transactions
- Exercise/Conversion
Common Stock
2008-12-22$0.23/sh+33,883$7,963→ 889,971 total - Exercise/Conversion
Stock Option (Right to Buy)
2008-12-22−33,883→ 0 totalExercise: $0.23Exp: 2009-07-01→ Common Stock (33,883 underlying)
Holdings
- 456,473(indirect: By Grat)
Common Stock
- 119,950(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The option vested in equal installments of approximately 1,211 shares each month beginning on August 1, 1999 through July 1, 2003.